Structure and Characterization of a Covalent Inhibitor of Src Kinase

Structure and Characterization of a Covalent Inhibitor of Src Kinase

Unregulated Src activity promotes malignant processes in cancer, but no Src-directed targeted therapies are used clinically, possibly because early Src inhibitors produce off-target effects leading to toxicity. Improved selective Src inhibitors may enable Src-directed therapies. Previously, we repor...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Deepak Gurbani, Guangyan Du, Nathaniel J. Henning, Suman Rao, Asim K. Bera, Tinghu Zhang, Nathanael S. Gray, Kenneth D. Westover
Materialtyp: Artikel
Språk:English
Publicerad: Frontiers Media S.A. 2020-05-01
Serie:Frontiers in Molecular Biosciences
Ämnen:
src kinase
cancer
dasatinib
selectivity
irreversible inhibitor
Länkar:https://www.frontiersin.org/article/10.3389/fmolb.2020.00081/full

Internet

https://www.frontiersin.org/article/10.3389/fmolb.2020.00081/full

Liknande verk